Results 31 to 40 of about 517,509 (243)

COVID-19-Associated severe autoimmune hemolytic anemia: A rare case report

open access: yesSaudi Journal of Medicine and Medical Sciences, 2021
Autoimmune hemolytic anemia (AIHA) is a very rare presentation of COVID-19, and AIHA due to COVID-19 alone (i.e., in the absence of an associated underlying disorder) is extremely rare. Warm agglutinin disease accounts for the majority of AIHA in general.
Lakshmi J Nair   +2 more
doaj   +1 more source

Biallelic PIGB Variants Cause Motor Neuropathy with Conduction Blocks and Peripheral Nerve Hyperexcitability

open access: yesAnnals of Neurology, EarlyView.
Objective Glycosylphosphatidylinositol (GPI)‐anchored proteins play critical roles in nervous system function. Pathogenic variants in genes involved in GPI‐anchor biosynthesis cause early‐onset multisystem disorders known as inherited GPI deficiencies. We describe a novel neuromuscular phenotype associated with PIGB deficiency.
Gorka Fernández‐Eulate   +34 more
wiley   +1 more source

Venetoclax as a trigger for autoimmune hemolytic anemia in secondary acute myeloid leukemia: A case report

open access: yesSAGE Open Medical Case Reports
Venetoclax, a BCL-2 inhibitor used in chronic lymphocytic leukemia and acute myeloid leukemia, has been rarely associated with autoimmune hemolytic anemia, mostly in chronic lymphocytic leukemia.
Karima Benallaoua   +4 more
doaj   +1 more source

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia

open access: yes, 2020
Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood cells with and without involvement of complement. It is associated with significant morbidity and mortality.
Irina Murakhovskaya
core   +1 more source

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz   +13 more
wiley   +1 more source

Autoimmune Hemolytic Anemia in a Dog [PDF]

open access: yes, 2014
Autoimmune Hemolytic Anemia is a naturally occurring disease of dogs characterized usually by thrombocytopenia, hemolytic anemia, reticulocytosis, and a positive direct anti-globulin test (Coomb's test).
Bryan, Joseph
core  

Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti   +9 more
wiley   +1 more source

Undetectable Glycosylated Hemoglobin in Autoimmune Hemolytic Anemia [PDF]

open access: yes, 2005
We encountered two cases of autoimmune hemolytic anemia (AIHA) with undetectable glycosylated hemoglobin (HbA1C) level at diagnosis.
Mitani, Noriyuki   +6 more
core  

Idiopathic intracranial hypertension with autoimmune hemolytic anemia: A rare association

open access: yesPediatric Hematology Oncology Journal, 2023
Background: Autoimmune hemolytic anemia (AIHA) is an acquired form of immune-mediated hemolytic anemia. Association of idiopathic intracranial hypertension (IIH) has been observed with iron deficiency anemia, parvovirus B-19 associated anemia, and ...
Jasmine Singh   +3 more
doaj   +1 more source

Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab

open access: yes, 2018
Autoimmune hemolytic anemia occurs due to an interaction of IgG antibodies with protein antigens expressed on red blood corpuscles. Glucocorticoids are the mainstay of treatment for autoimmune hemolytic anemia.
Renee K McAlister   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy